TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	169.39	178.69	133.36	120.03	161.41	34.79
Short-Term Investments	48.65	111.42	58.69	-	-	-
Cash & Short-Term Investments	218.05	290.11	192.04	120.03	161.41	34.79
Cash Growth	-26.75%	51.06%	60.00%	-25.64%	363.93%	-16.70%
Prepaid Expenses	3.09	2.61	2.19	4.1	4.25	1.65
Total Current Assets	221.13	292.72	194.24	124.13	165.65	36.45
Property, Plant & Equipment	70.62	71.6	71.23	69.2	17.26	12.53
Other Long-Term Assets	6.81	6.8	6.68	5.76	5.2	0.76
Total Assets	298.56	371.12	272.15	199.09	188.11	49.74
Accounts Payable	4.54	4.28	2.37	2.91	1.77	2.91
Accrued Expenses	12.61	15.33	10.29	6.41	5.51	2.36
Current Portion of Long-Term Debt	-	-	3.35	-	-	-
Current Portion of Leases	6.29	4.57	3.25	3.68	1.65	1.42
Current Unearned Revenue	7.7	11.7	10.14	3.87	11.41	10.63
Other Current Liabilities	0.19	0.08	0.43	0.43	1.01	0.13
Total Current Liabilities	31.32	35.96	29.82	17.31	21.34	17.45
Long-Term Debt	32.3	32.07	26.7	29.29	-	-
Long-Term Leases	58.12	60.74	59.14	53.01	4.39	6.02
Long-Term Unearned Revenue	-	1.25	5.62	-	1.5	8.82
Other Long-Term Liabilities	0.11	0.14	-	0.05	0.1	0.24
Total Liabilities	121.85	130.15	121.28	99.66	27.33	32.52
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	622.89	616.01	398.46	257.81	252.93	1.07
Retained Earnings	-446.18	-375.1	-247.6	-158.38	-92.16	-43.53
Comprehensive Income & Other	-0	0.05	-	-	-	-
Total Common Equity	176.71	240.97	150.87	99.43	160.78	-42.46
Shareholders' Equity	176.71	240.97	150.87	99.43	160.78	17.22
Total Liabilities & Equity	298.56	371.12	272.15	199.09	188.11	49.74
Total Debt	96.7	97.38	92.43	85.98	6.04	7.43
Net Cash (Debt)	121.35	192.73	99.61	34.04	155.36	27.36
Net Cash Growth	-41.27%	93.48%	192.60%	-78.09%	467.91%	-25.82%
Net Cash Per Share	2.14	3.41	2.08	1.42	13.32	29.87
Filing Date Shares Outstanding	56.75	56.59	47.88	24.23	23.86	1.14
Total Common Shares Outstanding	56.75	56.59	47.83	24.23	23.91	1.14
Working Capital	189.81	256.77	164.42	106.82	144.31	19
Book Value Per Share	3.11	4.26	3.15	4.10	6.72	-37.38
Tangible Book Value	176.71	240.97	150.87	99.43	160.78	-42.46
Tangible Book Value Per Share	3.11	4.26	3.15	4.10	6.72	-37.38
Machinery	-	22.59	18.63	16.87	12.15	6.14
Construction In Progress	-	0.1	0.55	0.01	1.26	0.78
Leasehold Improvements	-	3.26	3.16	3.45	3.43	0.49

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q